Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lysyl oxidase (LOX) is a copper-dependent amine oxidase enzyme that plays a central role in the biogenesis and maintenance of connective tissue matrices. Its primary function is to catalyze the oxidative deamination of specific lysine residues in collagen and elastin precursors, converting them into reactive aldehydes (allysine). These aldehydes then participate in covalent cross-linking reactions, which are essential for stabilizing the extracellular matrix (ECM) by forming mature collagen fibrils and elastic fibers. LOX expression is regulated by various factors, and dysregulation has been linked with tumor progression due to effects on cell migration/invasion via ECM remodeling. Inhibition of LOX is explored as a strategy to treat fibrotic diseases and cancer.
Inhibition of lysyl oxidase activity, preventing ECM cross-linking
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysyl Oxidase (LOX).